Bloodwork question about semaglutide. Baseline, three weeks in, and the numbers moved in a direction I did not expect.
There is a serious question about whether the studied form matches what is sold, and nobody in a thread can answer it.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Titration is slow by design and rushing it is how people end up miserable.
The interesting question is not whether it works but for whom and at what cost.
Sterility is the part people wave through and it is the part that actually bites.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.
What is the first thing you would read if you were starting from zero?